Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 5Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Not yet recruiting 2Active not recruiting 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 30INDUSTRY 22NETWORK 14NIH 12OTHER_GOV 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gynecologic 7

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

fluzoparib 1apatinib 1Paclitaxel 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Carcinoma, Ovarian Epithelial × Clear all
NCT05827523 2026-02-13

FOCUS / KOV-04

National Cancer Center, Korea

Phase 3 Recruiting
520 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

National Cancer Center, Korea

Phase 3 Active not recruiting
140 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02859038 2025-02-10

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

Shanghai Gynecologic Oncology Group

Phase 3 Active not recruiting
489 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Anhui Provincial Hospital

Phase 3 Not yet recruiting
51 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT04515602 2020-08-27

FOCUS

Shanghai Gynecologic Oncology Group

Phase 3 Not yet recruiting
410 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00850772 2014-06-12

OPEN

Queensland Centre for Gynaecological Cancer

Phase 3 Completed
109 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Malnutrition

NCT01654146 2012-07-31

ICON8

Medical Research Council

Phase 3 Unknown
1,485 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡